S.1310 - Dietary Supplement Labeling Act of 2011

A bill to improve the safety of dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to register dietary supplement products with the Food and Drug Administration and to amend labeling requirements with respect to dietary supplements. view all titles (2)

All Bill Titles

  • Official: A bill to improve the safety of dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to register dietary supplement products with the Food and Drug Administration and to amend labeling requirements with respect to dietary supplements. as introduced.
  • Short: Dietary Supplement Labeling Act of 2011 as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill’s Views

  • Today: 1
  • Past Seven Days: 7
  • All-Time: 7,822
 
Introduced
 
Senate
Passes
 
House
Passes
 
President
Signs
 

 
06/30/11
 
 
 
 
 
 
 

Official Summary

Dietary Supplement Labeling Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to expand the registration requirements for a dietary supplement manufacturing facility to: (1) require the submission of a description, ingredient list, and label and labeling for each dietary

Official Summary

Dietary Supplement Labeling Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to expand the registration requirements for a dietary supplement manufacturing facility to:
(1) require the submission of a description, ingredient list, and label and labeling for each dietary supplement product manufactured; and
(2) require a manufacturer to update its registration for new, reformulated, or discontinued products within 30 days. Requires the Secretary of Health and Human Services (HHS) to compile a list of dietary supplement ingredients and proprietary blends of ingredients that the Secretary determines could cause potentially serious adverse events, drug interactions, contraindications, or potential risks to subgroups such as children and pregnant or breastfeeding women. Directs the Secretary to enter into a contract with the Institute of Medicine to:
(1) evaluate the safety of dietary supplement ingredients and proprietary blends of ingredients that the Institute determines could cause potentially serious adverse events, drug interactions, contraindications, or potential risks to subgroups; and
(2) identify proprietary blends of ingredients for which the weight per serving of the ingredient in the proprietary blend should be provided on the label. Deems a dietary supplement that does not meet the requirements of this Act to be misbranded. Requires the Secretary to establish a definition for the term “conventional food” for purposes of the FFDCA, taking in account foods marketed as dietary supplements.

...Read the Rest

Organizations Supporting S.1310

  • None via MapLight at this time.

Organizations Opposing S.1310

  • Council for Responsible Nutrition
  • Alliance for Natural Health
  • Natural Products Association
  • Health Freedom Alliance
  • Hippocrates Health Institute
  • NuMedica
  • ...and 2 more. See all.


Latest Letters to Congress

See All Letters (30)
 


Vote on This Bill

11% Users Support Bill

3 in favor / 25 opposed
 

Send Your Senator a Letter

about this bill Support Oppose Tracking
Track with MyOC

Top-Rated Comments